Contraception
📧 Sign up to get email alerts when something new happens for Contraception.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-06-26FDA Approved: AUROVELA 1.5/30 — Original Application (Aurobindo Pharma Limited)
FDA approved AUROVELA 1.5/30 (norethindrone acetate and ethinyl estradiol) from Aurobindo Pharma Limited under an Original Application. It i…
-
FDA approval · 2017-06-16FDA Approved: AUROVELA FE 1/20 — Original Application (Aurobindo Pharma Limited)
The FDA approved AUROVELA FE 1/20 as a generic oral contraceptive under an Original Application (ANDA 207505). It combines norethindrone ace…
-
FDA approval · 2017-06-16FDA Approved: AUROVELA 1/20 — Original Application (Aurobindo Pharma Limited)
FDA approves AUROVELA 1/20 as an original application generic combined oral contraceptive containing norethindrone acetate and ethinyl estra…
-
FDA approval · 2017-06-15FDA Approved: TARINA 24 FE — Original Application (Afaxys Pharma, LLC)
The FDA approved Tarina 24 FE as a generic combination oral contraceptive (norethindrone acetate/ethinyl estradiol/ferrous fumarate) under A…
-
FDA approval · 2017-04-28FDA Approved: LO SIMPESSE — Original Application (Aurobindo Pharma Limited)
FDA approved LO SIMPESSE (levonorgestrel and ethinyl estradiol) under an original application for a generic oral contraceptive by Aurobindo …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives [NA]
This clinical trial update compares side effect profiles between brand-name and generic oral contraceptives, with results posted.
-
FDA approval · 2017-03-22FDA Approved: SIMLIYA — Original Application (Aurobindo Pharma Limited)
FDA approved SIMLIYA, a generic combined oral contraceptive containing desogestrel and ethinyl estradiol, under an Original Application (AND…
-
FDA approval · 2016-12-16FDA Approved: DEPO-SUBQ PROVERA — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for Depo-SubQ Provera, an injectable contraceptive containing medroxyprogesterone acetate, submi…
-
FDA approval · 2016-12-13FDA Approved: NORETHINDRONE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s norethindrone tablets under an Original Application. This represents approval of a generic norethindrone product…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle [NA]
This completed trial evaluated whether administering oral contraceptives at different times during the follicular phase affects outcomes rel…
-
FDA approval · 2016-11-14FDA Approved: AUBRA EQ — Original Application (Afaxys Pharma, LLC)
FDA approves the original ANDA for AUBRA EQ, a generic oral contraceptive containing levonorgestrel and ethinyl estradiol, manufactured by A…
-
FDA approval · 2016-10-27FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for a generic combined oral contraceptive containing norgestimate and ethinyl estra…
-
FDA approval · 2016-09-23FDA Approved: CHATEAL EQ — Original Application (Afaxys Pharma, LLC)
The FDA approved the original application for CHATEAL EQ, a generic fixed-dose combination oral contraceptive containing levonorgestrel and …
-
FDA approval · 2016-09-09FDA Approved: VOLNEA — Original Application (Xiromed, LLC.)
The FDA approved VOLNEA, a desogestrel and ethinyl estradiol oral contraceptive, via an original application submitted by Xiromed, LLC.
-
FDA label_change · 2016-08-26FDA Approved: NORTREL 7/7/7 (28 DAY REGIMEN) — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Nortrel 7/7/7 (28 day regimen), updating labeling to reflect a 28-day regimen for norethindrone …
-
FDA approval · 2016-08-23FDA Approved: AMAZON BASIC CARE LEVONORGESTREL — Supplemental Application (Amazon.com Services LLC)
FDA approved a supplemental application for Amazon Basic Care Levonorgestrel (levonorgestrel), a generic contraceptive product manufactured …
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Effect of Food on the Bioavailability of 15 mg Estetrol/3 mg Drospirenone Tablets in Healthy Female Volunteers [Phase 1]
Phase 1 study evaluating the effect of food on the bioavailability of Estetrol 15 mg / Drospirenone 3 mg tablets in healthy female volunteer…
-
FDA approval · 2016-07-28FDA Approved: VALTYA 1/35 — Original Application (Xiromed LLC)
FDA approved VALTYA 1/35, a generic combination oral contraceptive containing ethynodiol diacetate and ethinyl estradiol, from Xiromed LLC, …
-
FDA approval · 2016-07-06FDA Approved: TRI-MILI — Original Application (Aurobindo Pharma Limited)
FDA approves TRI-MILI (norgestimate and ethinyl estradiol) for contraception under Original Application by Aurobindo Pharma Limited.
-
FDA approval · 2016-06-16FDA Approved: AMETHYST — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for Amethyst (levonorgestrel and ethinyl estradiol) from Teva Pharmaceuticals, granting changes to a…
-
FDA approval · 2016-06-03FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL — Original Application (Nivagen Pharmaceuticals, Inc.)
FDA approved the original application for a generic oral contraceptive containing norethindrone acetate and ethinyl estradiol, manufactured …
-
FDA approval · 2016-05-26FDA Approved: DESOGESTREL AND ETHINYL ESTRADIOL — Supplemental Application (Mayne Pharma Inc.)
FDA approved a supplemental application for Mayne Pharma Inc.'s Desogestrel and Ethinyl Estradiol tablets (ANDA 091234).
-
FDA approval · 2016-04-26FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original application for NORGESTIMATE AND ETHINYL ESTRADIOL, a generic combined oral contraceptive.
-
FDA approval · 2016-03-23FDA Approved: WYMZYA FE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved WYMZYA FE, a generic combined oral contraceptive containing norethindrone and ethinyl estradiol, from Lupin Pharmaceuticals, un…
-
FDA approval · 2016-02-09FDA Approved: ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved a generic combination oral contraceptive containing ethynodiol diacetate and ethinyl estradiol (ANDA 204704) from Mylan.